Thymmune

About Thymmune

Thymmune is a Cambridge, Massachusetts-based biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The platform focuses on mass-producing iPSC-derived thymic cells to rejuvenate immune responses and enable off-the-shelf therapies. The company aims to develop a pipeline of therapies for immunodeficiencies, transplant-related immune issues, and autoimmune disorders, with a focus on scalable thymic cell manufacturing and immune restoration.